Evotec (OTCMKTS:EVTCY) Hits New 52-Week Low – Here’s What Happened

by · The Cerbat Gem

Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as $2.90 and last traded at $2.96, with a volume of 199176 shares traded. The stock had previously closed at $3.14.

Evotec Stock Down 2.0 %

The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The company has a market cap of $957.64 million, a price-to-earnings ratio of 7.07 and a beta of 0.98. The stock has a fifty day moving average price of $3.38 and a two-hundred day moving average price of $4.68.

About Evotec

(Get Free Report)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

Read More